Research and Development Archives – Treatment Action Group

New TAG Analysis: Nearly All Countries “Far Off Track” of Meeting TB Research Targets Despite Publicly Reaffirming Commitments at UN

September 20, 2023
Dorrit Walsh

As international dignitaries and political leaders gather in New York City this week for the United Nations High-Level Meeting (HLM) on TB, a sobering new analysis from Treatment Action Group (TAG) shows that governments failed to meet previous commitments to fund TB research.

Far Off Track: Funding for TB Research, 2018 – 2022

September 19, 2023
Dorrit Walsh

United Nations High-Level Meeting on TB Policy Note. At the first United Nations High-Level Meeting (HLM) on TB back in 2018, UN member states pledged “to mobilize sufficient and sustainable financing, with the aim of increasing overall global investments to…

HCV Elimination Among People Living with and at Risk of HIV: Challenges and Opportunities

September 5, 2023
Dorrit Walsh

Following the White House’s recent proposal for a National Hepatitis C Elimination Plan as part of its Fiscal Year 2024 budget request to Congress, and the fact that key populations for HIV are also at high risk of HCV, Treatment Action Group is organizing a webinar that will highlight best practices and challenges for HCV elimination with a specific focus on high-burden populations.

Information Note: New Fair Share Funding Targets for TB Research 0.1% -> 0.15%

August 16, 2023
Dorrit Walsh

In 2017 Treatment Action Group and partners introduced the “fair share” funding targets for TB research.

HIV Cure Research Information Sheet

March 17, 2023
Dorrit Walsh

Research into curing HIV infection is ever-changing as new discoveries are made and scientists report additional rare — but informative — cases of individuals likely cured of HIV.

TB Vaccine Development: The Next Chapter Starts Now

March 14, 2023
Dorrit Walsh

On Thursday, April 13, Treatment Action Group (TAG) presented this webinar about important developments in TB vaccine research.

Why Viral Load Can Be Detectable Despite Perfect Adherence

March 8, 2023
Dorrit Walsh

Webinar on March 22 that will provide an update on new research into cases in which the HIV reservoir generates detectable viral load that cannot be suppressed by antiretroviral therapy.

CROI 2023 Tuberculosis Research Round Up

February 22, 2023
Dorrit Walsh

Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI).

Treatment Action Group Resource on the Demographics of Participation in HIV Cure-Related Clinical Research

December 16, 2022
Dorrit Walsh

In 2014, TAG began tracking HIV cure-related trials and observational studies and making the information available as a listing on our website. The primary sources are online study registries, particularly the US-based clinicaltrials.gov.

publication cover, which reads: tuberculosis research funding trends, 2005 - 2021. Cover is blue with "$1 BILLION" in text over various monetary signs from different countries. Logos at bottom are StopTBPartnership and TAG

2022 Report on TB Research Funding Trends

December 6, 2022
Dorrit Walsh

For the first time in history, funding for tuberculosis (TB) research and development (R&D) hit a billion dollars worldwide in 2021.